Search Results

31 - 35 of 35 items :

  • Emergency Medicine and Intensive-Care Medicine x
Clear All
Toxic Megacolon – A Three Case Presentation

difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality. Clin Infect Dis. 2015;61(2):233-41. 22. Dubberke ER, Sadhu J, Gatti R, et al. Severity of Clostridium difficile-associated disease (CDAD) in allogeneic stem cell transplant recipients: evaluation of a CDAD severity grading system. Infect Control Hosp Epidemiol. 2007;28:208–11. 23. Henrich TJ, Krakower D, Bitton A, Yokoe DS. Clinical Risk Factors for Severe Clostridium difficile–associated Disease. Emerg Infect Dis. 2009

Open access
The Role of Carotid Ultrasonography in Patients with High Risk of Atherosclerosis

;163:517-522. 34. Mester A, Oltean-Péter B, Rodean I, et al. Magnetic Resonance Imaging of Myocardial Function Following Intracoronary and Intramyocardial Stem Cell Injection. Journal of Interdisciplinary Medicine . 2017;2:112-116. 35. Inzitari D, Eliasziw M, Gates P, et al. The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med . 2000;342:1693-1700. 36. Fox Allan J. How to measure carotid stenosis. Radiology . 1993;186:316-318. 37

Open access
Cardiac Magnetic Resonance and Myocardial Viability: Why Is It so Important?

Imaging of Myocardial Function Following Intracoronary and Intramyocardial Stem Cell Injection. Journal of Interdisciplinary Medicine . 2017;2:112-116. 8. Bax JJ, Delgado V. Myocardial viability as integral part of the diagnostic and therapeutic approach to ischemic heart failure. J Nucl Cardiol . 2015;22:229-245. 9. Saeed M, Liu H, Liang CH, Wilson MW. Magnetic resonance imaging for characterizing myocardial diseases. Int J Cardiovasc Imaging . 2017. doi: 10.1007/s10554-017-1127-x. [Epub ahead of print] 10. Buckert D, Kelle S, Buss S, et al. Left

Open access
Medication-Related Osteonecrosis of the Jaw: a Brief Review, Treatment and Practical Guidelines for Dentists

;101:11-23. 58. Agrillo A, Filiaci F, Ramieri V, Riccardi E, Quarato D, Rinna C. Bisphosphonate-related osteonecrosis of the jaw (BRONJ): 5 year experience in the treatment of 131 cases with ozone therapy. Eur Rev Med Pharmacol Sci . 2012;16:1741–1747. 59. Gonzálvez-García M, Rodríguez-Lozano FJ, Villanueva V, Segarra-Fenoll D, Rodríguez-González MA, Oñate-Sánchez R. Cell therapy in bisphosphonate-related osteonecrosis of the jaw. J Craniofac Surg . 2013;24:e226–e228. 60. Cella L, Oppici A, Arbasi M, Moretto M, Piepoli M, Vallisa D. Autologous bone marrow stem

Open access
Extracorporeal Life Support and New Therapeutic Strategies for Cardiac Arrest Caused by Acute Myocardial Infarction - a Critical Approach for a Critical Condition

.0012. 3. Gyongyosi M, Hemetsberger R, Posa A, et al. Hypoxia-inducible Factor 1-Alp[ha Release After Intracoronary versus Intramyocardial Stem Cell Therapy in Myocardial Infarction. J Cardiovasc Translational Res. 2010;3:114-21. doi: 10.1007/s12265-009-9154-1. 4. Benedek I, Gyongyosi M, Benedek T. A prospective regional registry of ST-elevation myocardial infarction in central Romania. Impact of the Stent for Life initiative recommendations on patient outcomes. Am Heart J. 2013;166:457-65. doi: 10.1016/j.ahj.2013.03.033. 5. Avalli L, Maggioni E, Formica F

Open access